We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breast Milk Appears to Kill HIV cells

By HospiMedica International staff writers
Posted on 27 Jun 2012
An unknown component of breast milk kills HIV particles and virus-infected cells, as well as blocking HIV-transmission in mice with a human immune system, according to a new study.

Researchers at University of North Carolina (UNC; Chapel Hill, USA) created bone marrow, liver, and thymus (BLT) mice that underwent reconstitution of the oral cavity and upper gastrointestinal (GI) tract using humanized leukocytes, including the human cell types important for mucosal HIV transmission (i.e., dendritic cells, macrophages, and CD4+ T cells). More...
The BLT mice were susceptible to oral transmission of cell-free and cell-associated HIV, which resulted in systemic infection of lymphoid and nonlymphoid tissues characterized by the presence of HIV RNA in plasma and a gradual decline of CD4+ T cells in peripheral blood.

The researchers found, however, that if the BLT mice were fed breast milk contaminated with HIV, the virus was not transmitted. The in vivo results demonstrated that breast milk had a strong inhibitory effect on oral transmission of both cell-free and cell-associated HIV. Finally, the researchers evaluated the effect of antiretrovirals on oral transmission of HIV, showing that systemic antiretrovirals administered prior to exposure could also efficiently prevent oral HIV transmission in BLT mice. The study was published on June 14, 2012, in PLoS Pathogens.

“These results are highly significant because they show that breast milk can completely block oral transmission of both forms of HIV that are found in the breast milk of HIV- infected mothers, virus particles and virus-infected cells,” said lead author Angela Wahl, MD, of the UNC Center for AIDS Research. “This refutes the 'Trojan horse' hypothesis which says that HIV in cells is more stubborn against the body's own innate defenses than HIV in virus particles.”

Pediatric HIV infection is associated with an accelerated course of disease and high mortality rate. In the absence of antiretroviral therapy, only 65% of HIV-infected children survive until their first birthday, and less than half will reach two years of age. The question arises as to why some breastfed babies born to HIV-positive mothers contract the virus, if breast milk does not transmit HIV? The answer might be that suckling on cracked nipples may expose babies to the HIV virus present in their mother's blood.

Related Links:

University of North Carolina




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.